An Entity of Type: animal, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

David Grainger is a partner at medicxi, a European life sciences-oriented venture capital firm and chief executive officer of Methuselah Health Ltd., a drug development company doing proteomics research in the longevity space. He was formerly with Index Ventures, an international venture capital firm with offices in London, Geneva and San Francisco, in the firm's life sciences practice. He also writes for Forbes.com on topics related to the pharmaceutical industry.

Property Value
dbo:abstract
  • ديفيد غرينجر (بالإنجليزية: David Grainger)‏ هو عالم بريطاني، ولد في 12 أكتوبر 1966. (ar)
  • David Grainger is a partner at medicxi, a European life sciences-oriented venture capital firm and chief executive officer of Methuselah Health Ltd., a drug development company doing proteomics research in the longevity space. He was formerly with Index Ventures, an international venture capital firm with offices in London, Geneva and San Francisco, in the firm's life sciences practice. He also writes for Forbes.com on topics related to the pharmaceutical industry. (en)
dbo:almaMater
dbo:birthDate
  • 1966-10-12 (xsd:date)
dbo:birthYear
  • 1966-01-01 (xsd:gYear)
dbo:occupation
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 41678342 (xsd:integer)
dbo:wikiPageLength
  • 10171 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1096027455 (xsd:integer)
dbo:wikiPageWikiLink
dbp:almaMater
dbp:birthDate
  • 1966-10-12 (xsd:date)
dbp:caption
  • Partner at Index Ventures, blogger (en)
dbp:name
  • David Grainger (en)
dbp:occupation
  • venture capitalist, medicxi, biotechnology executive, Methuselah Health Ltd., blogger (en)
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • ديفيد غرينجر (بالإنجليزية: David Grainger)‏ هو عالم بريطاني، ولد في 12 أكتوبر 1966. (ar)
  • David Grainger is a partner at medicxi, a European life sciences-oriented venture capital firm and chief executive officer of Methuselah Health Ltd., a drug development company doing proteomics research in the longevity space. He was formerly with Index Ventures, an international venture capital firm with offices in London, Geneva and San Francisco, in the firm's life sciences practice. He also writes for Forbes.com on topics related to the pharmaceutical industry. (en)
rdfs:label
  • ديفيد غرينجر (ar)
  • David Grainger (en)
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
foaf:name
  • David Grainger (en)
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License